======= PCID2 ======= == Gene Information == * **Official Symbol**: PCID2 * **Official Name**: PCI domain containing 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55795|55795]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5JVF3|Q5JVF3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PCID2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PCID2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613713|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |PCI| |posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery| |transcription export complex 2| |nuclear retention of pre-mRNA at the site of transcription| |positive regulation of mitotic cell cycle spindle assembly checkpoint| |positive regulation of spindle checkpoint| |transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery| |positive regulation of cell cycle checkpoint| |intracellular mRNA localization| |positive regulation of B cell differentiation| |nuclear pore nuclear basket| |nuclear RNA surveillance| |regulation of mitotic cell cycle spindle assembly checkpoint| |regulation of mitotic spindle checkpoint| |nuclear mRNA surveillance| |regulation of spindle checkpoint| |RNA surveillance| |poly(A)+ mRNA export from nucleus| |transcriptionally active chromatin| |regulation of B cell differentiation| |regulation of cell cycle checkpoint| |spleen development| |regulation of mitotic metaphase/anaphase transition| |regulation of metaphase/anaphase transition of cell cycle| |regulation of mitotic sister chromatid separation| |regulation of chromosome separation| |regulation of mitotic sister chromatid segregation| |transcription elongation from RNA polymerase II promoter| |regulation of sister chromatid segregation| |negative regulation of cysteine-type endopeptidase activity| |DNA-templated transcription, elongation| |positive regulation of lymphocyte differentiation| |double-stranded DNA binding| |regulation of chromosome segregation| |mRNA-containing ribonucleoprotein complex export from nucleus| |mRNA export from nucleus| |ribonucleoprotein complex export from nucleus| |ribonucleoprotein complex localization| |RNA export from nucleus| |positive regulation of leukocyte differentiation| |protein export from nucleus| |positive regulation of mitotic cell cycle| |mRNA transport| |nuclear export| |positive regulation of B cell activation| |regulation of mitotic nuclear division| |regulation of lymphocyte differentiation| |regulation of mRNA stability| |regulation of RNA stability| |positive regulation of hemopoiesis| |regulation of nuclear division| |nucleic acid transport| |RNA transport| |establishment of RNA localization| |nuclear-transcribed mRNA catabolic process| |regulation of mRNA catabolic process| |regulation of B cell activation| |mRNA catabolic process| |RNA localization| |nucleobase-containing compound transport| |regulation of cysteine-type endopeptidase activity| |negative regulation of endopeptidase activity| |RNA catabolic process| |negative regulation of peptidase activity| |protein-containing complex localization| |nucleocytoplasmic transport| |nuclear transport| |regulation of leukocyte differentiation| |positive regulation of cell cycle process| |regulation of mRNA metabolic process| |regulation of chromosome organization| |negative regulation of proteolysis| |positive regulation of lymphocyte activation| |nucleobase-containing compound catabolic process| |positive regulation of cell cycle| |positive regulation of leukocyte activation| |regulation of mitotic cell cycle phase transition| |regulation of endopeptidase activity| |positive regulation of cell activation| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |aromatic compound catabolic process| |regulation of peptidase activity| |regulation of cell cycle phase transition| |cellular component| |regulation of hemopoiesis| |negative regulation of hydrolase activity| |organic cyclic compound catabolic process| |transcription by RNA polymerase II| |regulation of lymphocyte activation| |posttranscriptional regulation of gene expression| |regulation of leukocyte activation| |hematopoietic or lymphoid organ development| |regulation of mitotic cell cycle| |regulation of cell activation| |transcription, DNA-templated| |nucleic acid-templated transcription| |immune system development| |RNA biosynthetic process| |mRNA metabolic process| |regulation of proteolysis| |regulation of cell cycle process| |negative regulation of catalytic activity| |regulation of cellular catabolic process| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |cellular macromolecule catabolic process| |positive regulation of cell differentiation| |negative regulation of cell death| |regulation of catabolic process| |intracellular protein transport| |negative regulation of cellular protein metabolic process| |macromolecule catabolic process| |chromosome organization| |nucleobase-containing compound biosynthetic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |positive regulation of immune system process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |regulation of cell cycle| |regulation of hydrolase activity| |regulation of organelle organization| |organic cyclic compound biosynthetic process| |positive regulation of developmental process| |RNA binding| |protein transport| |intracellular transport| |peptide transport| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |regulation of programmed cell death| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |RNA metabolic process| |regulation of cell death| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |macromolecule biosynthetic process| |organic substance catabolic process| |cellular catabolic process| |regulation of cell differentiation| |establishment of localization in cell| |nitrogen compound transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.16| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-1.87| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-1.79| |[[:results:exp112|S-DABN 8μM R03 exp112]]|1.73| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|1.84| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.485| |[[:human genes:h:hars|HARS]]|0.433| Global Fraction of Cell Lines Where Essential: 438/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|20/28| |blood|14/28| |bone|15/26| |breast|20/33| |central nervous system|31/56| |cervix|3/4| |colorectal|13/17| |esophagus|6/13| |fibroblast|0/1| |gastric|10/16| |kidney|10/21| |liver|11/20| |lung|57/75| |lymphocyte|10/16| |ovary|17/26| |pancreas|18/24| |peripheral nervous system|10/16| |plasma cell|9/15| |prostate|1/1| |skin|10/24| |soft tissue|5/9| |thyroid|2/2| |upper aerodigestive|7/22| |urinary tract|17/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 285 * **Expression level (log2 read counts)**: 6.57 {{:chemogenomics:nalm6 dist.png?nolink |}}